
The DABOM is a platform company specializing in the mass production of artificial exosomes using microfluidic technology and artificial intelligence. Their vision is to become a global leader in exosome therapeutics, aiming to free humans from diseases through advanced micro-nano technology. The company has developed Artificial Exosomes for Nanomedicine (ExocureTM) and an Artificial Exosome Mass-Producing Platform (ExostationTM). They have also secured several patents related to exosome synthesis and purification methods. The DABOM has received recognition and funding, including being selected for the Deep Tech TIPS program and a national project by the Ministry of Food and Drug Safety.

The DABOM is a platform company specializing in the mass production of artificial exosomes using microfluidic technology and artificial intelligence. Their vision is to become a global leader in exosome therapeutics, aiming to free humans from diseases through advanced micro-nano technology. The company has developed Artificial Exosomes for Nanomedicine (ExocureTM) and an Artificial Exosome Mass-Producing Platform (ExostationTM). They have also secured several patents related to exosome synthesis and purification methods. The DABOM has received recognition and funding, including being selected for the Deep Tech TIPS program and a national project by the Ministry of Food and Drug Safety.